The world’s first vaccine trial against elephant endotheliotropic herpesvirus (EEHV)—a leading cause of death in young Asian elephants—is safe and triggers a strong virus-fighting immune response, according to an international team led by the University of Surrey, in collaboration with Chester Zoo and the Animal and Plant Health Agency.
Vaccine for deadly elephant herpesvirus found safe and effective in early trial
